160 results
Page 5 of 8
8-K
EX-99.1
lzgkex08 vbn
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
wv1h 11pk
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
CORRESP
cxzc1rojtsa
13 Dec 19
Correspondence with SEC
12:00am
8-K
EX-99.1
dz7hxjs6p9tw7cpl4j42
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
733bt3ws560
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
npr07srhln1mhdtsq
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
o21uree8nf8cy8z6f70q
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
s8uil4htlwg3 89
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
bvne73mka 4w7
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
oxr2tdl 00
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
luih46x5c unwm
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
a5b73gvsbac
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
rkocoxx7qqs7z
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
98hmuw t2gs
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
8kykq0pxo3 2ad0
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
0drng22w
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
gwcwjl 0g
24 Jul 19
Other Events
9:46pm
8-K
EX-99.2
58p v5kptuph
24 Jul 19
Other Events
9:46pm